enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Siponimod - Wikipedia

   en.wikipedia.org/wiki/Siponimod

   Siponimod is indicated for the treatment of secondary progressive multiple sclerosis, which is the progressive neurological decline of multiple sclerosis that happens independent of acute relapses. [1] In active secondary progressive multiple sclerosis, siponimod decreases the risk of disability and multiple sclerosis relapses. [1]

3. Multiple sclerosis drug pipeline - Wikipedia

   en.wikipedia.org/wiki/Multiple_sclerosis_drug...

   Cyclophosphamide (Revimmune) is in Phase III trials for secondary progressive MS. [78] It was also studied for RRMS but the company does not pursue actively this path. In a 2006 study for refractory cases it showed some effectiveness [ 79 ] A 2007 open label study found it equivalent to mitoxantrone [ 80 ] and in 2008 evidence appeared that it ...

4. Ublituximab - Wikipedia

   en.wikipedia.org/wiki/Ublituximab

   Ublituximab is indicated for the treatment of relapsing-remitting, active secondary progressive, and clinically isolated syndrome forms of multiple sclerosis in adults. [ 1 ] [ 4 ] [ 6 ] In the European Union, ublituximab is indicated for the treatment of adults with relapsing forms of multiple sclerosis (RMS) with active disease defined by ...

5. New treatment may stop and potentially reverse some nerve ...

   www.aol.com/treatment-may-stop-potentially...

   Multiple sclerosis (MS) is an autoimmune disorder in which the immune system attacks and destroys the myelin sheath of nerve cells. It most commonly strikes people between the ages of 20 and 40.

6. Sanofi's tolebrutinib drug delays progressive MS by 31% in trial

   www.aol.com/news/sanofis-tolebrutinib-drug...

   Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end of MS pill Au Sanofi's tolebrutinib drug delays progressive MS by 31% in ...

7. Mitoxantrone - Wikipedia

   en.wikipedia.org/wiki/Mitoxantrone

   This combination was once the first line of treatment; however, a combination of docetaxel and prednisone improves survival rates and lengthens the disease-free period. [3] Mitoxantrone is also used to treat multiple sclerosis (MS), most notably the subset of the disease known as secondary-progressive MS.